pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Small Molecule · news · pharmadog
← back to Small Molecule
News · Small Molecule
467
stories
Jul 7, 26
Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trials
endpoints
Jul 1, 26
Merck scraps a Phase 2 Alzheimer's asset from partner Neuphoria
endpoints
Jul 1, 26
Abivax shares surge as worries subside over immune drug’s cancer risk
biopharma dive
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 30, 26
Beeline ups its Series A round for immune drug work
biopharma dive
Jun 29, 26
FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing
fda press
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 26, 26
FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences services
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
Jun 18, 26
cAMPfield lands $180M to build gut disease drug
biopharma dive
Jun 18, 26
Pfizer CFO to step down; Denali sells a regulatory fast-pass
biopharma dive
Jun 18, 26
STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more
stat
Jun 18, 26
Innoviva revives Lyndra's long-acting oral drug platform
endpoints
Jun 16, 26
Edgewise heart drug passes key trial test
biopharma dive
Jun 16, 26
STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
stat
Jun 12, 26
Merck brings Welireg-Keytruda combo to treat kidney cancer
endpoints
Jun 12, 26
FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children
fda press
Jun 11, 26
J&J looks to widen Imaavy’s use; $300M backs rare disease drug launch
biopharma dive
Jun 11, 26
Takeda's plaque psoriasis pill beats Bristol Myers' Sotyktu in Phase 3
endpoints
Jun 11, 26
Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test
biopharma dive
Jun 10, 26
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine
biopharma dive
Jun 9, 26
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
biopharma dive
Jun 9, 26
Gilead and Merck’s latest trial success and flop
stat
Jun 9, 26
Alcohol study discarded by Trump officials is published in scientific journal
stat
Jun 8, 26
#ADA26: AstraZeneca's GLP-1 pill cuts weight by 10.5% after six months
endpoints
Jun 8, 26
STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
stat
Jun 8, 26
City banks nearly $100M for next-gen RNAi drugs
biopharma dive
Jun 8, 26
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
biopharma dive
Jun 3, 26
What it will take for more employer GLP-1 coverage
endpoints
Jun 3, 26
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
stat
← prev
page 11 of 16
next →
